184.177 articles found

USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS.

GOMEZ-MANCILLA BALTAZAR, FEUERBACH DOMINIK, JOHNS DONALD, PAOLO THERESE DI.

· 2012-03-21

Methylphenidate exposure induces dopamine neuron loss and activation of microglia in the basal ganglia of mice.

Sadasivan S, Pond BB, Pani AK, Qu C, Jiao Y, Smeyne RJ.

PLoS One · 2012-03-21

DOI: 10.1371/journal.pone.0033693PMID: 22470460

Nicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from Pellagra.

Williams AC, Hill LJ, Ramsden DB.

Curr Gerontol Geriatr Res · 2012-03-21

DOI: 10.1155/2012/302875PMID: 22536229

α-Synuclein phosphorylation as a therapeutic target in Parkinson's disease.

Braithwaite SP, Stock JB, Mouradian MM.

Rev Neurosci · 2012-03-21

DOI: 10.1515/revneuro-2011-0067PMID: 22499677

Motor signs in the prodromal phase of Parkinson's disease.

Maetzler W, Hausdorff JM.

Mov Disord · 2012-03-21

DOI: 10.1002/mds.24973PMID: 22437964

Ibuprofen ameliorates protein aggregation and astrocytic gliosis, but not cognitive dysfunction, in a transgenic mouse expressing dementia with Lewy bodies-linked P123H β-synuclein.

Sekiyama K, Fujita M, Sekigawa A, Takamatsu Y, Waragai M, Takenouchi T, Sugama S, Hashimoto M.

Neurosci Lett · 2012-03-21

DOI: 10.1016/j.neulet.2012.03.037PMID: 22459406

Comparing movement patterns associated with Huntington's chorea and Parkinson's dyskinesia.

Mann RK, Edwards R, Zhou J, Fenney A, Jog M, Duval C.

Exp Brain Res · 2012-03-21

DOI: 10.1007/s00221-012-3057-0PMID: 22434341

Suggested immobilization test for diagnosis of restless legs syndrome in Parkinson's disease.

De Cock VC, Bayard S, Yu H, Grini M, Carlander B, Postuma R, Charif M, Dauvilliers Y.

Mov Disord · 2012-03-21

DOI: 10.1002/mds.24969PMID: 22437899

Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.

Alcalay RN, Caccappolo E, Mejia-Santana H, Tang M-, Rosado L, Orbe Reilly M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, Andrews H, Waters C, Fahn S, Cote L, Frucht S, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Siderowf A, Payami H, Molho E, Factor S, Ottman R, Clark LN, Marder K.

Neurology · 2012-03-21

DOI: 10.1212/wnl.0b013e318253d54bPMID: 22442429

The role of the GABA(B) receptor and calcium channels in a Drosophila model of Parkinson's Disease.

Hillman R, Sinani J, Pendleton R.

Neurosci Lett · 2012-03-21

DOI: 10.1016/j.neulet.2012.03.034PMID: 22480689

Antagonist muscle co-activation during straight walking and its relation to kinematics: insight from young, elderly and Parkinson's disease.

Arias P, Espinosa N, Robles-García V, Cao R, Cudeiro J.

Brain Res · 2012-03-21

DOI: 10.1016/j.brainres.2012.03.033PMID: 22502978

Animal models of L-DOPA-induced dyskinesia: an update on the current options.

Iderberg H, Francardo V, Pioli EY.

Neuroscience · 2012-03-21

DOI: 10.1016/j.neuroscience.2012.03.023PMID: 22465440